At a glance
- Originator Zenyaku Kogyo
- Class
- Mechanism of Action Choline acetyltransferase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cognition-disorders in Japan
- 08 Feb 2002 Preclinical development for Cognition disorders in Japan (Unknown route)